Bugs, drugs, and HIV: the role of the vaginal microbiome in HIV risk and antiretroviral efficacy for HIV prevention

DSpace/Manakin Repository

Bugs, drugs, and HIV: the role of the vaginal microbiome in HIV risk and antiretroviral efficacy for HIV prevention

Citable link to this page

 

 
Title: Bugs, drugs, and HIV: the role of the vaginal microbiome in HIV risk and antiretroviral efficacy for HIV prevention
Author: Liebenberg, Lenine J. P.; Archary, Derseree; Sivro, Aida; Kwon, Douglas S.

Note: Order does not necessarily reflect citation order of authors.

Citation: Liebenberg, Lenine J. P., Derseree Archary, Aida Sivro, and Douglas S. Kwon. 2017. “Bugs, drugs, and HIV: the role of the vaginal microbiome in HIV risk and antiretroviral efficacy for HIV prevention.” Genome Medicine 9 (1): 74. doi:10.1186/s13073-017-0469-2. http://dx.doi.org/10.1186/s13073-017-0469-2.
Full Text & Related Files:
Abstract: Editorial summary Advances in molecular tools to characterize the microbiome have led to the discovery of unique roles for microbes in human disease. Findings that the female genital microbiome can influence HIV acquisition and prevention emphasize the importance of microbiome analysis in clinical trials that assess the efficacy of HIV prevention interventions.
Published Version: doi:10.1186/s13073-017-0469-2
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561602/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:34375026
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters